Antitumor Activity and Pharmacokinetics of TAS-106, 1-(3-C-Ethyny1-β-D-ribo-pentofuranosyl)cytosine

• SHIMAMOTO Yuji

  The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd

• FUJIOKA Akio

  The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd

• KAZUNO Hiromi

  The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd

• MURAKAMI Yuko

  The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd

• OHSHIMO Hideyuki

  The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd

• KATO Toshiyuki

  The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd

• MATSUDA Akira

  Graduate School of Pharmaceutical Sciences, Hokkaido University

• SASAKI Takuma

  Cancer Research Institute, Kanazawa University

• FUKUSHIMA Masakazu

  The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd

収録刊行物

• Japanese journal of cancer research : gann

  Japanese journal of cancer research : gann 92 (3), 343-351, 2001-03-31

キーワード

• 1-(3-C-Ethynyl-β-D-ribo-pentofuranosyl)cytosine
• TAS-106
• TAS-106 nucleotides
• Antitumor activity
• Pharmacokinetics

詳細情報

• CRID: 1572543024535152640
• NII論文ID: 10008061514
• NII書誌ID: AA00690844
• ISSN: 09105050
• Web Site: https://search.jamas.or.jp/link/ui/2001210104
• 本文言語コード: en
• データソース種別:
  • CiNii Articles